Starpharma Holdings: Notice of Annual General Meeting/Proxy Form

Oct 5, 2026 at 11:44 PM EDT · Issued by Starpharma Holdings Limited via ASX

Filed with ASX · Oct 5, 2026 at 11:44 PM EDT · 27 pages · English

On 6ix: 6ix.com/news/notice-of-annual-general-meetingproxy-form-747

Release

Delivering meaningful patient outcomes with advanced dendrimer technologyNotice of Annual General Meeting 2026 Starpharma Holdings Limited Notice of Meeting 2026 1 Invitation from the Chair Dear Shareholder, I am pleased to invite you to the 2026 Annual General Meeting (AGM or Meeting) of...

Starpharma Holdings Limited on 6ix

Story so far

Change of Director's Interest Notice - C MaleyOct 4, 2026
Change of Director Interest Notice - R BasserAug 13, 2026
Change of Director Interest Notice - R ThomasAug 13, 2026

Earlier from Starpharma

Change of Director's Interest Notice - C MaleyOct 4
Application for quotation of securities - SPLOct 4
Notification of cessation of securities - SPLOct 4
Chair and Deputy Chair AppointmentsSep 30
Ceasing to be a substantial holderSep 25

Later from Starpharma

Change in substantial holdingOct 7
Trading HaltOct 15
Starpharma secures majority ownership of PetalionOct 19
Starpharma Investor Presentation Petalion WebinarOct 20
$3.5 Million R&D Tax Incentive ReceivedOct 21

All Starpharma news releases

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma